Cargando…

Metabolic impact of weight loss induced reduction of adipose ACE-2 – Potential implication in COVID-19 infections?

BACKGROUND & AIMS: Angiotensin converting enzyme (ACE)-2 is a modulator of adipose tissue metabolism. However, human data of adipose ACE-2 is rarely available. Considering that, ACE-2 is believed to be the receptor responsible for cell entry of SARS-CoV-2, a better understanding of its regulatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Linna, Spranger, Leonard, Soll, Dominik, Beer, Finja, Brachs, Maria, Spranger, Joachim, Mai, Knut
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2020
Materias:	COVID-19 in Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552972/ https://www.ncbi.nlm.nih.gov/pubmed/33065163 http://dx.doi.org/10.1016/j.metabol.2020.154401

Ejemplares similares

Fetuin-B, a potential link of liver-adipose tissue cross talk during diet-induced weight loss–weight maintenance
por: Li, Linna, et al.
Publicado: (2021)

Weight loss-induced improvement of body weight and insulin sensitivity is not amplified by a subsequent 12-month weight maintenance intervention but is predicted by adaption of adipose atrial natriuretic peptide system: 48-month results of a randomized controlled trial
por: Li, Linna, et al.
Publicado: (2022)

Long-term impact of the metabolic status on weight loss-induced health benefits
por: Soll, Dominik, et al.
Publicado: (2022)

SARS-CoV-2 adipose tissue infection and hyperglycemia: A further step towards the understanding of severe COVID-19
por: Tsilingiris, Dimitrios, et al.
Publicado: (2022)

Excess body weight is an independent risk factor for severe forms of COVID-19
por: Pietri, Léa, et al.
Publicado: (2021)

Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells
por: Kimura, Hiroki, et al.
Publicado: (2020)

Involvement of Spike Protein, Furin, and ACE2 in SARS-CoV-2-Related Cardiovascular Complications
por: Ming, Yi, et al.
Publicado: (2020)

The impact of the COVID-19 pandemic on incident cases of chronic diseases in Finland
por: Wikström, Katja, et al.
Publicado: (2022)

Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon
por: Finney, Lydia J., et al.
Publicado: (2021)

Lung ACE2 and ADAM17 in pulmonary arterial hypertension: Implications for COVID-19?
por: Pérez-Vizcaíno, Francisco
Publicado: (2020)

Treatment Options Available for COVID-19 and an Analysis on Possible Role of Combination of rhACE2, Angiotensin (1-7) and Angiotensin (1-9) as Effective Therapeutic Measure
por: Muslim, Shahnawaz, et al.
Publicado: (2020)

Glucose-Dependent Insulinotropic Polypeptide Reduces Fat-Specific Expression and Activity of 11β-Hydroxysteroid Dehydrogenase Type 1 and Inhibits Release of Free Fatty Acids
por: Gögebakan, Özlem, et al.
Publicado: (2012)

Obesity in patients with COVID-19: a systematic review and meta-analysis
por: Huang, Yi, et al.
Publicado: (2020)

Diabetes, glycaemic control, and risk of COVID-19 hospitalisation: Population-based, prospective cohort study
por: Hamer, Mark, et al.
Publicado: (2020)

Association of obesity and its genetic predisposition with the risk of severe COVID-19: Analysis of population-based cohort data
por: Zhu, Zhaozhong, et al.
Publicado: (2020)

Visceral fat shows the strongest association with the need of intensive care in patients with COVID-19
por: Watanabe, Mikiko, et al.
Publicado: (2020)

Commentary. Eliminating vitamin D deficiency during the COVID-19 pandemic: A call to action
por: Manson, JoAnn E., et al.
Publicado: (2020)

Pro-fibrotic M2 macrophage markers may increase the risk for COVID19 in type 2 diabetes with obesity()()
por: Moin, Abu Saleh Md, et al.
Publicado: (2020)

Commentary: Statins, COVID-19, and coronary artery disease: killing two birds with one stone
por: Ganjali, Shiva, et al.
Publicado: (2020)

The incidence of COVID-19 in patients with metabolic syndrome and non-alcoholic steatohepatitis: A population-based study()
por: Ghoneim, Sara, et al.
Publicado: (2020)

Association of body mass index (BMI) with critical COVID-19 and in-hospital mortality: A dose-response meta-analysis
por: Du, Yanbin, et al.
Publicado: (2021)

Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
por: Zheng, Kenneth I., et al.
Publicado: (2020)

The combination of bromelain and curcumin as an immune-boosting nutraceutical in the prevention of severe COVID-19
por: Kritis, Panagiotis, et al.
Publicado: (2020)

Commentary: Myths and facts on vitamin D amidst the COVID-19 pandemic
por: Chakhtoura, M., et al.
Publicado: (2020)

Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19
por: Dalamaga, Maria, et al.
Publicado: (2020)

The serum metabolome of COVID-19 patients is distinctive and predictive
por: Shi, Ding, et al.
Publicado: (2021)

COVID-19 editorial: mechanistic links and therapeutic challenges for metabolic diseases one year into the COVID-19 pandemic
por: Tessier, Christopher M., et al.
Publicado: (2021)

Visceral fat is associated to the severity of COVID-19
por: Favre, Guillaume, et al.
Publicado: (2021)

Impact of body composition on COVID-19 susceptibility and severity: A two-sample multivariable Mendelian randomization study
por: Freuer, Dennis, et al.
Publicado: (2021)

SARS-CoV-2 and diabetes: A potential therapeutic effect of dipeptidyl peptidase 4 inhibitors in diabetic patients diagnosed with COVID-19
por: Kifle, Zemene Demelash, et al.
Publicado: (2021)

Systematic review with meta-analysis of diagnostic test accuracy for COVID-19 by mass spectrometry
por: Spick, Matt, et al.
Publicado: (2022)

Drug repurposing in COVID-19: A review with past, present and future
por: Srivastava, Kamna, et al.
Publicado: (2021)

Thromboembolism risk among patients with diabetes/stress hyperglycemia and COVID-19
por: Calvisi, Stefania L., et al.
Publicado: (2021)

A review on protective roles and potential mechanisms of metformin in diabetic patients diagnosed with COVID-19
por: Kifle, Zemene Demelash, et al.
Publicado: (2021)

Diabetic ketoacidosis in pediatric patients with type 1- and type 2 diabetes during the COVID-19 pandemic()
por: Loh, Charlotte, et al.
Publicado: (2021)

Reduction of in-hospital non-COVID-19 pneumonia in stroke patients during the COVID-19 pandemic
por: Ornello, Raffaele, et al.
Publicado: (2023)

Weight of risk factors for mortality and short-term mortality displacement during the COVID-19 pandemic
por: ASTENGO, MATTEO, et al.
Publicado: (2022)

Increased ACE2 Expression in Bronchial Epithelium of COPD Patients who are Overweight
por: Higham, Andrew, et al.
Publicado: (2020)

SARS-CoV-2 infection of thymus induces loss of function that correlates with disease severity
por: Rosichini, Marco, et al.
Publicado: (2023)

Impact of the first COVID-19 lockdown on body weight: A combined systematic review and a meta-analysis
por: Bakaloudi, Dimitra Rafailia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ncpvbnp3rqa35nin4sbp5n0n4h